Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07642388

Scaling up the Integrated Care Pathway for Acute Asthma to All Osakidetza Pediatric Services Through a Cluster-randomized SMART Design

Conditions: Asthma in Children

Sex: All
Ages: 2 Years – 14 Years
Healthy volunteers: No
Phase: NA
Enrollment: 4680
Sponsor: Basque Health Service

Location: Primary Care Research Unit of Bizkaia Barakaldo Bizkaia

Summary

The main goal of this study is to evaluate the effectiveness of adaptive sequential implementation strategies based on facilitation in promoting the sustainable and widespread adoption and scaling up of the Integrated Care Pathway for Acute Asthma - ASMAbat across all Primary Care and Hospital Pediatric Services of Osakidetza - Basque Health Service.

Eligibility Criteria

Eligibility for healthcare settings: \- All Pediatric Services (Primary Care n=108 and Hospital Care n=9) from 11 of the 13 Osakidetza Integrated Healthcare Organizations that are not currently implementing the ASMAbat Pathway. Eligibility for professionals: * Primary Care pediatricians and nurses * Pediatricians and nurses in the Pediatric Emergency Department * Pediatricians and nurses on the inpatient ward * Pediatric Intensive Care pediatricians and nurses * Pediatric Pneumology pediatricians and nurses Eligibility for patients: Patients between 2 and 14 years that have being attended between the 1st of July 2026 and the 28th of February 2029, and with an acute episode of asthma, defined as: * an episode of wheezing and a previous diagnosis of asthma or with a previous episode of wheezing * a first episode in a child older than 2 years with a personal/family history of atopy and/or with an objective response to bronchodilators as assessed by a severity Score

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07642388). StuddyBuddy aggregates publicly available trial information.